IN SILICO INVESTIGATION OF ECHINODERMATA SECONDARY METABOLITES AS HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) REVERSE TRANSCRIPTASE INHIBITORS by NAZWIR, NURRAHMA et al.
International Journal of Applied Pharmaceutics
ISSN - 0975 - 7058 Vol 12, Special Issue 1, 2020
IN SILICO INVESTIGATION OF ECHINODERMATA SECONDARY METABOLITES AS HUMAN 
IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) REVERSE TRANSCRIPTASE INHIBITORS
NURRAHMA NAZWIR, ARRY YANUAR, REZI RIADHI SYAHDI*
Department of  Pharmaceutical Chemistry, Biomedical Computation Laboratory, Faculty of Pharmacy, Universitas Indonesia, Depok 
16424, Indonesia. Email: rezi.riadhi@farmasi.ui.ac.id
Received: 02 October 2019, Revised and Accepted: 24 December 2019 
ABSTRACT
Objective: Human immunodeficiency virus (HIV) targets the immune system and weakens immune surveillance and defenses against infections, 
leading to acute immunodeficiency syndrome. Recent trends in drug discovery from natural sources emphasize investigations of compounds from 
marine ecosystems.
Methods: In this study, we compiled a database of chemical compounds from echinoderms and virtually screened for those that inhibit HIV-1 reverse 
transcriptase (RT). The database was generated from literature searches. Virtual screening analyses for inhibitors of HIV-1 RT were then performed 
using AutoDock software.
Results: Based on screening results, the top thirteen ranked compounds were nobilisidenol B, Ech_005, 17-deoxyholothurinogenin, 
22,25-oxidoholothurinogenin, Ech_022, Ech_026, Ech_021, nobilisidenol A, Ech_025, 5α-cholest-8(14)-ene-3ß,7α-diol, astropecten A, Ech_004, and 
phrygiasterol.
Conclusion: The present in silico screening analyses of compounds from marine ecosystems can be used to identify candidate compounds with high 
potential as drugs for the treatment of refractory HIV infections.
Keywords: Echinoderms, Human immunodeficiency virus, Reverse transcriptase inhibitor.
INTRODUCTION
Marine environments are known sources of unique and potent 
compounds with pharmacological properties such as antitumor, 
anti-inflammatory, analgesic, immunomodulatory, anti-allergy, and 
antiviral activities [1]. Yet compounds from marine environments have 
not yet been investigated extensively and have only been researched, 
collected, extracted, and explored chemically since the mid-late 1960s. 
In comparison, compounds from terrestrial environments have been 
exploited by humans for more than 3000 years [2]. Hence, marine 
resources may provide alternative candidate compounds for new 
active drugs for the treatment of various diseases, such as human 
immunodeficiency virus type 1 (HIV-1), a disease that remains a major 
global public health issue [3]. Among marine organisms, echinoderms are 
exclusively found in salt water, with no fresh water or terrestrial members 
or similar organisms have been identified [4]. Hence, novel compounds/
new chemical entities that are peculiar to marine environments are 
likely to differ from those of terrestrial organisms. Previous researches 
have shown echinoderm compounds with reported antiviral activities 
include imbricantine from Dermasterias imbricata [5,6], four new 
sulfated polar steroids from the Far Eastern starfish Leptasterias 
ochotensis [7], hedathiosulfonic acids A and B from Echinocardium 
cordatum [6,8], lysastroside from Lysastrosoma anthosticta [6,9], and 
ten saponin compounds from Certonardoa semiregularis [10]. In silico 
analyses may offer valuable research information and reduce the costs 
of drug development by reducing sample numbers in in vitro and in vivo 
studies [11]. Several studies have shown that virtual screening could 
be performed for marine compounds to target various macromolecules 
such as epidermal growth factor receptor-TK, vascular EGFR-2, mouse 
double minute 2, and procaspase-3 [12-14]. Herein, we performed in 
silico molecular docking experiments to identify the most promising 




Two dimensional (2D) structures of echinoderms bioactive compounds 
were compiled by data mining numerous journals. Subsequently, three 
dimensional (3D) structures were created in MarvinSketch [15] using 
mmff94 force field and strict level optimization limits. The prepared 
ligands were saved in *.pdb files and were converted to *.pdbqt files.
Macromolecule preparation
Macromolecules were downloaded from the Protein Data Bank using 
3LP1 code [16]. Macromolecules were then prepared by separating 
from solvents, ligands, and other nonstandard residues using 
AutoDockTools [17]. We then optimized these by deleting water 
molecules, adding nonpolar hydrogen atoms, charges, and force fields, 
and by minimizing the structures using AutoDockTools. Prepared 
macromolecules were saved in *.pdb files and were then converted to 
*.pdbqt files.
Docking parameter optimization
In silico docking was performed using AutoDock 4.0 [17], which was 
run automatically through PyRx [18], and the results were visualized 
using PyMOL [19] and LigandScout [20]. Molecular docking parameters 
were optimized by redocking nevirapine. Positive controls included 
nevirapine, delavirdine, efavirenz, rilpivirine, and etravirine, which 
are recommended by the United States Food and Drug Administration 
(FDA) for the treatment of HIV-1 [21].
Virtual screening
Virtual screening was performed with HIV-1 RT using the AutoDock 
function of PyRx. The parameters were as follows: Search space 
surrounding the binding pocket, 18.75 × 18.75 × 18.75 Å; maximum 
number of generations, 27,000; maximum number of energy of 
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evaluations, 250,000; number of individuals in population, 150; 
number of genetic algorithm runs, 10; rate of gene mutation, 0.02; and 




We initially prepared macromolecules by searching the protein 
database and deleting nonstandard residues. The nonstandard 
residues nevirapine ligand, manganese ion (II), and LP8 were then 
separated from structures as identifier molecules. Hydrogen atoms 
that are not generally identified in crystal structures were then added 
to manipulate hydrogen bonding with added ligands. AutoDock force 
field was then applied with Gasteiger charges as a common default 
for docking in AutoDock applications. We then performed energy 
minimization to identify geometrical conformations with the least 
optimal energy so that the structures could be considered stable as 
docking targets. The coordinates of the nevirapine binding site were 
determined as a positive control and the binding site was defined as 
x = 10.350, y = 14.076, and z = 18.252. The grid was set at 50 × 50 × 50 
units at 0.375 Å. This coordinate determination for the receptor target 
corresponded with previous research [28].
Ligand database preparation
The ligand database that was developed in this experiment comprised 
ligand names from the International Union of Pure and Applied 
Chemistry (IUPAC), 2D and 3D structures, species names from which 
the compounds were extracted/isolated, and pharmacological actions 
(if any) and references. Data from various journals were obtained from 
the PubChem Open Chemistry Database [26], the ChemSpider Search 
and Share Chemistry [29] and other resources in *.sdf and *.mol formats. 
Hydrogen atoms were added because the software scoring function 
requires polar and nonpolar hydrogen atoms. Gasteiger charges and 
AutoDock force fields were added because they are generally used in 
AutoDock software. Some of the compounds that were compiled from 
journals already have names, whereas others have only IUPAC names. 
To facilitate docking and analysis, ligand nomenclature for unnamed 
compounds was standardized as Ech_XXX, where XXX are three-digit 
numbers of compounds that were sorted based on literature reviews.
Analysis of virtual screening results
Virtual screening was performed for 127 compounds that were 
identified by data mining of several journals. Virtual screening tests of 
RT inhibitory activities of ligands were sorted and ranked based on ∆G 
values. Compounds with the lowest ∆G values were placed in the first 
rank. The results are listed in Table 1.
Based on our screening results, the top thirteen ranked compounds 
were nobilisidenol B, Ech_005, 17-deoxyholothurinogenin, 
22,25-oxidoholothurinogenin, Ech_022, Ech_026, Ech_021, 
nobilisidenol A, Ech_025, 5α-cholest-8(14)-ene-3ß,7α-diol, astropecten 
A, Ech_004, and phrygiasterol. These compounds were selected for 
further analysis based on energy bond values that were superior to 
those of the positive control (Table 3). Etravirine was identified as a 
non-nucleoside RT inhibitor (NNRTI) and had bond energy of −8.82 
kcal/mol [28]. All compounds were selected based on their anti-HIV 
activities. Based on the literature searches and reviews, these thirteen 
compounds have not been identified as anti-HIV or RT inhibitors 
previously.
Visualization of virtual screening results
After identifying top compounds based on ranking, their active sites 
were observed from validation and virtual screening of docking results 
and were visualized using LigandScout. After analyzing and visualizing 
chemical bonds and interactions between cocrystals or positive 
controls and receptor targets, interactions between validated bioactive 
compounds from echinoderms and RT were analyzed and visualized in 
terms of hydrogen bond lengths using PyMOL. In these experiments, 
the most important interactions were weak intermolecular forces 
comprising hydrogen bonds and hydrophobic interactions. These 
are key properties for stabilizing ligands in open conformations of 
protein structures. Specifically, hydrogen bonds are formed through 
interactions between hydrogen atoms that are covalently bound to 
electronegative donor atoms with electronegative acceptor atoms. 
These interactions are important for proteins and occur predominantly 
between NH and CO groups of main α-helical chains. Hydrogen bonds 
between macromolecules and their ligands (proteins, nucleic acids, 
substrates, effectors, and inhibitors) contribute directionality and 
specificity of interactions and serve as fundamental mediators of 
molecular recognition [30-33].
In 2009, Eugene E. Kwan classified hydrogen bonds with donor-acceptor 
distances of 2.2–2.5 Å as “strong, mostly covalent,” of 2.5–3.2 Å as 
“medium, mostly electrostatic,” and of 3.2–4.0 Å as “weak, electrostatic” 
[33]. This hydrogen bonds classification is defined in Table 2.
Analysis and visualization of interactions between compounds 
from echinoderms and macromolecule targets using AutoDock
2D and 3D structures of docking results were modeled using 
LigandScout. As shown in Fig. 1, the highest-ranked compound 
nobilisidenol B was docked to 3LP1. This triterpene was isolated from 
the sea cucumber Holothuria nobilis [22].
The LigandScout analysis and visualization of 2D and 3D structures 
identified two hydrogen bonds. In one of these, nobilisidenol B provides 
a hydrogen bond donor and an acceptor from the same amino-acid 
residue Tyr318. The nobilisidenol B functional group that acted as both 
H-bond donor (HB1) and acceptor (HB2) comprises hydroxyl groups of 
the phenanthrene core, with distances of 3.2 Å and 2.8 Å, respectively. 
These distances were measured using PyMOL and showed that HB1 is 
a medium H-bond and HB2 is a weak H-bond. Moreover, hydrophobic 
interactions were identified between nobilisidenol B and the amino-
acid residues Ile180, Leu100, Tyr181, Val106, and Val179.
Interactions between the positive control and the thirteen compounds 
from echinoderms and amino-acid residues are shown in Table 3.
Some amino-acid residues that play important roles as NNRTI binding 
sites are listed in Table 3. Among these, Lys101 is considered important 
because it has the most interactions of all 3LP1 amino-acid residues, 
which participates in hydrogen and ionic bonds with some compounds 
from echinoderms more than with other amino-acid residues. In a 
book published in 2006, Skowron and Ogden wrote about a number 
Table 2: Classification of hydrogen bond strength
Indicator Strong Medium Weak
Bond energy (kcal/mol) 14–40 4–14 0–4













Bond angle (°) 175–180 130–180 90–150
Source: Kwan, E. E., 2009 [33]
Fig. 1: Visualization of interactions between nobilisidenol B and 
3LP1
Source: LigandScout
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of hydrogen-bonding interactions between NNRTIs and protein main-
chain atoms. They suggest that the most commonly observed hydrogen 
bonds involve carbonyl groups of Lys101 [34]. Hydrogen bonding 
with Lys103 and Pro236 main-chain atoms has also been observed. In 
addition, we observed hydrogen-bonding interactions between Lys101 
and the selected compounds Ech_021, Ech_022, Ech_025, Ech_026, and 
phrygiasterol. Ionic interactions were also observed between the NH3+ 
group of Lys101 and SO42- groups of the compounds Ech_005, Ech_021, 
and Ech_022.
Interactions between Lys101 and SO42− ions deserve special attention 
because they have not been recognized in the previous studies of NNRTI 
binding sites. Accordingly, no NNRTI drugs that were approved by the 
FDA have reported ionic-bonding interactions with Lys101. Therefore, 
due to SO42− groups that participate in ionic interactions with Lys101, 
the echinoderm compounds Ech_005, Ech_021, and Ech_022 are 
promising candidate NNRTI drugs, along with the other top thirteen 
ranked compounds.
CONCLUSION
Database and literature searches of chemical compounds from 
echinoderms revealed 127 candidate compounds. Subsequent 
virtual screening for RT inhibitory activities using AutoDock 
identified nobilisidenol B, Ech_005, 17-deoxyholothurinogenin, 
22,25-Oxidoholothurinogenin, Ech_022, Ech_026, Ech_021, 
nobilisidenol A, Ech_025, 5α-cholest-8(14)-ene-3ß,7α-diol, astropecten 
A, Ech_004, and phrygiasterol as high potential candidate anti-HIV 
drugs.
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